Online therapy for anxiety after heart issues
Official title: Digital Cognitive Behavioral Therapy for Cardiac Anxiety Following Acute Coronary Syndrome: a Randomized Controlled Trial Comparing CBT to a Digital Lifestyle Intervention
Run by Karolinska Institutet · NCT06298864 · Data updated 2026-11-12
This study is testing an online therapy program to see if it can help people recovering from heart issues feel less anxious and improve their quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 176 (estimated) |
| Sponsor | Karolinska Institutet Academic / other |
| Locations | 1 site (Stockholm) |
| Status | Recruiting |
| Started | March 7, 2024 |
| Main results expected | October 31, 2026 |
| Study ends | October 31, 2027 |
| Registry record updated | September 16, 2025 |
| Trial ID | NCT06298864 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who have experienced ACS at least 6 months prior and are experiencing clinically significant cardiac anxiety.
✕Probably not a fit
Patients with severe heart failure, significant valvular disease, or ongoing psychological treatment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates an online Cognitive Behavioral Therapy (CBT) program designed for patients recovering from Acute Coronary Syndrome (ACS) to reduce cardiac anxiety, improve quality of life, and encourage physical activity. Participants will be randomly assigned to either the internet-based CBT group or an active control group receiving internet-based cardiac lifestyle intervention. Both groups will receive weekly therapist support through online communication over an 8-week period. The study aims to determine the effectiveness of the online CBT protocol in alleviating anxiety and enhancing overall well-being in ACS patients.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce cardiac anxiety and improve the quality of life for patients recovering from ACS.
How similar studies have gone: Previous studies have shown promise in using online CBT for anxiety management, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ACS ≥ 6 months before assessment (type 1 MI STEMI/NSTEMI or unstable angina \[UA\]) * Age 18 and older * Clinically significant cardiac anxiety that leads to distress and/or interferes with daily life (Cardiac Anxiety Questionnaire; CAQ: ≥18 * Able to read and write in Swedish Exclusion Criteria: * Heart failure New York heart Association class IV or ejection fraction ≤ 30% * Significant valvular disease * Planned coronary artery bypass surgery or percutaneous interventions * Any medical restriction to physical exercise * Severe medical illness or an acute health threatening disease (e.g., cancer) * Grade 3 hypertension (i.e., blood pressure ≥ 180 systolic and/or 110 diastolic) * Severe mental illness requiring urgent psychiatric hospitalization or intervention, or risk of suicide * Alcohol or substance use disorder that would impede ability to complete study protocol * Ongoing psychological treatment
Where it's running
-
Karolinska University Hospital
Stockholm, Sweden Recruiting
Study contacts
- Study coordinator: Josefin Särnholm, Lic psychologist, PhD
- Email: josefin.sarnholm@ki.se
- Phone: + 46 852483258
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Common femoral vein-to-artery diameter ratio to detect elevated LVEDP
Researchers test whether the ratio of the common femoral vein to artery diameters, measured by ultrasound, can flag elevated LV end-diastolic pressure in patients having coronary angiography.
-
Intrahospital flu vaccine for adults with high cardiovascular risk when admitted for ACS or heart failure
This study tests whether offering a flu vaccine at the bedside during a hospital stay, along with counseling, increases vaccination rates for adults with acute coronary syndrome or heart failure who are at high cardiovascular risk.
-
Digital lifestyle platform after rehabilitation to support self-management
A digital, patient-facing platform is being tested to see if people who recently finished inpatient rehabilitation will use it and benefit from personalized lifestyle guidance at home.
-
AI-driven Medipixel fractional flow reserve to guide PCI
This test checks whether an AI-based, angiography-derived Medipixel FFR method can guide PCI as safely and effectively as standard invasive pressure-wire FFR in adults with coronary artery disease.
-
Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions
This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.
-
AI-assisted interpretation of chest pain CT in the emergency department
A pragmatic randomized trial tests whether an AI tool (Angiomics) helps emergency physicians interpret coronary CT angiography in adults with acute chest pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.